Episode 340: Cancer Immunity Cycle Update

Ira Mellman delves into the update of “The cancer-immunity cycle: Indication, genotype, and immunotype,” and the components of an effective anti-tumor immune response.

Mellman previously served as vice president of biotechnology corporation Genentech.